RhoVac Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

RhoVac General Information

Description

Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.

Contact Information

Website
www.rhovac.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Medicon Village, Scheeletorget 1
  • 223 63 Lund
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Chosa Oncology
Vertical(s)
Corporate Office
  • Medicon Village, Scheeletorget 1
  • 223 63 Lund
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RhoVac Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RhoVac‘s full profile, request access.

Request a free trial

RhoVac Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic can
Drug Discovery
Lund, Sweden
13 As of 2021

Lund, Sweden
 

Lund, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RhoVac Competitors (5)

One of RhoVac’s 5 competitors is Cantargia, a Formerly VC-backed company based in Lund, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cantargia Formerly VC-backed Lund, Sweden
BioInvent International Formerly VC-backed Lund, Sweden
Atara Biotherapeutics Formerly VC-backed Thousand Oaks, CA
Active Biotech Corporation Lund, Sweden
Anocca Venture Capital-Backed Sodertalje, Sweden
You’re viewing 5 of 5 competitors. Get the full list »

RhoVac Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RhoVac Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RhoVac‘s full profile, request access.

Request a free trial

RhoVac FAQs

  • When was RhoVac founded?

    RhoVac was founded in 2007.

  • Where is RhoVac headquartered?

    RhoVac is headquartered in Lund, Sweden.

  • What is the size of RhoVac?

    RhoVac has 13 total employees.

  • What industry is RhoVac in?

    RhoVac’s primary industry is Drug Discovery.

  • Is RhoVac a private or public company?

    RhoVac is a Private company.

  • What is the current valuation of RhoVac?

    The current valuation of RhoVac is .

  • What is RhoVac’s current revenue?

    The current revenue for RhoVac is .

  • How much funding has RhoVac raised over time?

    RhoVac has raised $2.55M.

  • Who are RhoVac’s investors?

    M2 Asset Management and Swedish Growth Fund have invested in RhoVac.

  • Who are RhoVac’s competitors?

    Cantargia, BioInvent International, Atara Biotherapeutics, Active Biotech, and Anocca are competitors of RhoVac.

  • When was RhoVac acquired?

    RhoVac was acquired on 18-Jan-2023.

  • Who acquired RhoVac?

    RhoVac was acquired by Chosa Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process